Evaluation of the CRISPR Cas9 System As Genome Editing Platform for the Mucopolysaccharidosis IV A Using a Strategy for Induction of Higher Homologous Recombination Frequency. Univ. Sci. 2025, 30, 82-106. https://doi.org/10.11144/.